Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Aug 1;17(10):3659-3662.
doi: 10.1016/j.radcr.2022.07.030. eCollection 2022 Oct.

Facial myonecrosis following COVID-19

Raymond Zhao  1 , Hadi Saab  1 , Anthony Propson  2 , Toshio Moritani  1 , John Kim  1
Affiliations
Case Reports

Facial myonecrosis following COVID-19

Raymond Zhao et al. Radiol Case Rep. .

Abstract

Myositis and myonecrosis are rare sequela of coronavirus disease 2019 (COVID-19). Until now, it has not been seen in muscles of the head and neck. We present a 22-year-old male with 4 months of retroauricular headaches following COVID-19 infection. Magnetic resonance imaging revealed rim-enhancing fluid collections in the bilateral masticator spaces which were sampled by fine-needle aspiration. We also discuss this case in the context of the current understanding of COVID-19-related myositis.

Keywords: ADC, apparent diffusion coefficient; COVID-19; COVID-19, coronavirus disease 2019; CT, computed tomography; DWI, diffusion-weighted imaging; MRI, magnetic resonance imaging; Myonecrosis; Myositis.

PubMed Disclaimer

Figures

Fig 1
Fig. 1
(A) T2-weighted fat-suppressed and (B) contrast-enhanced T1-weighted DIXON fat-suppressed images show rim-enhancing fluid collections (arrows) involving the anterior aspect of the bilateral masticator spaces. (C) Diffusion-weighted and corresponding (D) apparent diffusion coefficient (ADC) map shows facilitated diffusion in the center of the fluid collections.
See this image and copyright information in PMC

References

    1. Vakili K, Fathi M, Pezeshgi A, Mohamadkhani A, Hajiesmaeili M, Rezaei-Tavirani M, et al. Critical complications of COVID-19: a descriptive meta-analysis study. Rev Cardiovasc Med. 2020;21(3):433–442. doi: 10.31083/j.rcm.2020.03.129. - DOI - PubMed
    1. Saud A, Naveen R, Aggarwal R, Gupta L. COVID-19 and myositis: what we know so far. Curr Rheumatol Rep. 2021;23(8):63. doi: 10.1007/s11926-021-01023-9. Published 2021 Jul 3. - DOI - PMC - PubMed
    1. Talotta R, Robertson E. Autoimmunity as the comet tail of COVID-19 pandemic. World J Clin Cases. 2020;8(17):3621–3644. doi: 10.12998/wjcc.v8.i17.3621. - DOI - PMC - PubMed
    1. Zacharias H, Dubey S, Koduri G, D'Cruz D. Rheumatological complications of Covid 19. Autoimmun Rev. 2021;20(9) doi: 10.1016/j.autrev.2021.102883. - DOI - PMC - PubMed
    1. Megremis S, Walker TDJ, He X, Ollier W, Chinoy H, Hampson L, et al. Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis. Ann Rheum Dis. 2020;79(10):1383–1386. doi: 10.1136/annrheumdis-2020-217522. - DOI - PMC - PubMed

Publication types

LinkOut - more resources